DGAP-News: Tetra Bio-Pharma Inc.: Tetra Bio-Pharma Receives Positive Opinion for Orphan Drug Designation for QIXLEEF from the European Medicines Agency

DGAP-News: Tetra Bio-Pharma Inc. / Key word(s): Miscellaneous Tetra Bio-Pharma Receives Positive Opinion for Orphan Drug Designation for QIXLEEF from the European Medicines Agency 21.10.2021

Related Keywords

United States ,Canada ,Munich ,Bayern ,Germany ,Ottawa ,Ontario ,Natalie Leroux ,Tetra Bio Pharma Inc ,European Commission ,Distribution Services ,Committee For Orphan Medicinal Products ,European Union ,European Medicines Agency ,Health Canada ,News Service ,Regulation Services Provider ,Tetra Bio Pharma ,Bio Pharma Receives Positive Opinion ,Orphan Drug Designation ,Orphan Medicinal Products ,Complex Regional Pain Syndrome ,Guy Chamberland ,Chief Executive Officer ,Chief Regulatory Officer ,Scientific Advice ,Regional Pain Syndrome ,Corporate News ,Regulatory Announcements ,Dgap ,News ,Setra ,Dharma ,Eceives ,Positive ,Opinion ,Orphan ,Drug ,Resignation ,Ixleef ,Rom ,European ,Medicines ,Agency ,